Unlock precision medicine in autoimmunity

Powered by world’s leading immunometabolism
platform

Rheos is a precision medicine company using insights from immunometabolism to bring novel therapeutics to patients suffering from autoimmune diseases. Our proprietary platform elucidates the complexities and heterogeneity of immune-mediated disease by investigating multi-omic datasets through a metabolic lens. This insight drives a deep pipeline of biomarker-enabled small molecule precision therapies.

Deep Precision Pipeline

Continuous and efficient advancement of small molecule therapeutics

Biomarker Activity

Target engagement and pharmacodynamics enhance success

Disease Segmentation

Matching the right drugs to the right patients

Expanded Diseases

Application of core capabilities into new areas of biology to enable expansion & partnering

Our
difference is our Team

Come be part of the journey!

Our platform gives us insights into the specific drivers of patients’ disease – advancing the delivery of the right treatment to the right patient at the right time.